Periodontal Disease and Incident Dementia: The Atherosclerosis Risk in Communities Study (ARIC)
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: To test the hypothesis that periodontal disease would be associated with increased risk for dementia and mild cognitive impairment (MCI) we prospectively assessed dementia/MCI outcomes following a baseline periodontal examination.
Methods: Participants enrolled in the Atherosclerosis Risk in Communities Study with a clinical periodontal examination (or edentulous participants) at visit 4 (1996-1998; mean±SD age=63±6, 55% female, 21% black) and adjudicated dementia outcomes through 2016 were included (n=8,275). A subgroup of 4,559 participants had adjudicated dementia and MCI assessments at visit 5 (2011-2013). Participants received a full-mouth periodontal exam and were classified into periodontal profile classes (PPCs) based on the severity and extent of gingival inflammation and attachment loss. MCI and dementia were determined via neurocognitive testing, neurological exam and history, informant interviews, and brain MRI in a subset. Cox proportional hazards models regressed incident dementia on PPCs. Relative risk regression models were utilized for the composite of MCI/dementia.
Results: The cumulative incidence and incidence density of dementia during follow-up (average=18.4 years) were 19% (n=1569) and 11.8 cases per 1,000 person-years. Multivariable adjusted hazard ratios (HRs) [95% CI] for incident dementia among participants with severe-PPC or edentulism (vs. periodontal healthy) were 1.22[1.01-1.47] and 1.21[0.99-1.48], respectively. For the combined dementia/MCI outcome adjusted risk ratios among participants with mild/intermediate-PPC, severe-PPC or edentulism (vs. periodontal healthy) were 1.22[1.00-1.48], 1.15[0.88-1.51] and 1.90[1.40-2.58]. Results were stronger among younger (<62 years) participants, p-value for interaction=0.02.
Conclusion: Periodontal disease was modestly associated with incident MCI and dementia in a community-based cohort of black and white participants.
- Received August 23, 2019.
- Accepted in final form April 6, 2020.
- © 2020 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease
Dr. Rizwan S. Akhtar and Dr. Sarah Brooker
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Dementia in late-onset epilepsyThe Atherosclerosis Risk in Communities studyEmily L. Johnson, Gregory L. Krauss, Anna Kucharska-Newton et al.Neurology, October 23, 2020 -
Article
Quantity and quality of mental activities and the risk of incident mild cognitive impairmentJanina Krell-Roesch, Jeremy A. Syrjanen, Maria Vassilaki et al.Neurology, July 10, 2019 -
Articles
Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairmentVonetta M. Dotson, May A. Beydoun, Alan B. Zonderman et al.Neurology, July 05, 2010 -
Article
APOE ε2ε4 genotype, incident AD and MCI, cognitive decline, and AD pathology in older adultsShahram Oveisgharan, Aron S. Buchman, Lei Yu et al.Neurology, May 11, 2018